Sustainability at Roche

Our approach

For over 120 years Roche has been committed to improving lives. The long-term thinking of our founders has allowed us to stay true to this vision. Our greatest contribution to society is lasting innovation. When acting sustainably, we also aim to provide a rewarding workplace, be a trustworthy partner and engage in the communities we work in and with.

Severin Schwan on sustainability

Severin Schwan, CEO of the Roche Group, on sustainability. "Developing medicines and tests is our main contribution to society."

Balance life

Roche commits to flexibility at the workplace and empowers people to deliver meaningful outcomes with balance.

The Roche story

The story of Roche underscores our longstanding commitment to creating a partnership between business and science that improves people’s lives.

Our impact on society

Innovating for patients

Providing a great workplace

Being a trustworthy partner

Environment and communities

Delivering continuous growth

Innovating for patients

127 million patients

treated with Roche medicines

>20 billion tests

conducted with Roche Diagnostics products

32 Roche medicines

on the WHO Model List of Essential Medicines

Providing a great workplace

72% employee engagement rate


30% of women

in key leadership positions

22% of key leaders

with diverse work experience

Being a trustworthy partner

23 new partnerships

in Diagnostics in 2018

107 new partnerships

in Pharmaceuticals in 2018


of approximately 1,000 business-critical suppliers risk-assessed

Environment and communities

13% decrease

in water consumption since 2015

10% decrease

in energy consumption since 2015

23% improvement

in the eco-balance since 2014

Delivering continuous growth

+7% in Group sales


+9% in core operating profit


10 years in a row

Group leader in Dow Jones Sustainability Index

Explore our stories

Our reporting

Roche is committed to transparent reporting and we endeavour to drive our economic, social and environmental performance with the same diligence as our financial performance.

External recognition

Our sustainability efforts have been recognised by key ratings such as Dow Jones Sustainability Indices (DJSI) or the Access to Medicine Index (AtMI).

Roche has been again recognised as one of the most sustainable healthcare companies in the Pharmaceutical Group of the Dow Jones Sustainability Indices 2019. This great result is based on an independent analysis of our economic, social and environmental performance.

Roche ranked 10th in the AtMI in 2018. The Index analyses large research-based healthcare companies on how they make their products more accessible in low- and middle-income countries.